SecBot SecBot
SECBOTREPLAY Home › Report › MLYS

MLYS · Two top executives at Mineralys Therapeutics, the CEO and Chief Medical…

Mineralys Therapeutics, Inc. · CLUSTER filed Apr 8, 2026 at 20:00 ET

At the news

BEARISHIMPACT 7/10

CLUSTER filed Apr 8, 2026 at 20:00 ET

Two top executives at Mineralys Therapeutics, the CEO and Chief Medical Officer, sold shares in a concentrated 7-day window, generating over $1.1 million in proceeds. The sales are open-market transactions, indicating deliberate divestment rather than routine equity management.

  • CEO Jon Congleton sold $422,000 worth of shares in a single open-market transaction on April 13, 2026.
  • Chief Medical Officer Rodman David Malcom sold $548,672 in shares across two days (April 13 and 15), following derivative exercises totaling $6,857.
  • Total open-market sale value from the cluster: $1.1M over 7 days, representing 0.048% of the company's $2.3B market cap.
  • All transactions were coded as S (open-market sale) or M (exercise of derivative), with non-cash derivative exercises also occurring.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access